Last reviewed · How we verify

NCT04164628

Evaluation of Quality of Life in Women

Completed NA Last updated 30 June 2020
What this trial tests

NA trial testing Quality of life assessment in Quality of Life in 227 participants. Completed in 28 June 2020.

Timeline
30 November 2019
Primary endpoint
1 June 2020
28 June 2020

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment227
Start date30 November 2019
Primary completion1 June 2020
Estimated completion28 June 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 to 60, female only, with Quality of Life or Women Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

300 women will be evaluated in this study. Their quality of life, level of physical activity, Social Functioning, levels of depression and musculoskeletal status will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Quality of life assessment

Trials testing the same drug.

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04164628.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing